Biocept reported $61.94M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Becton, Dickinson and BDX:US $ 53199M 1587M
Biocept BIOC:US $ 61.94M 1.53M
Celldex Therapeutics CLDX:US $ 402.96M 21.08M
Cerulean Pharma CERU:US $ 49.19M 6.62M
Cytori Therapeutics CYTX:US $ 21.27M 3.24M
General Electric GE:US $ 185540M 6421M
Illumina ILMN:US $ 15274M 57M
Quest Diagnostics DGX:US $ 13312M 130M
Thermo Fisher Scientific TMO:US $ 90579M 2168M